NORMA Group’s Investor Relations activities seek to further increase awareness of the company on the capital market, strengthen long-term confidence in the company’s management and achieve a fair valuation of the company. This implies commenting on the strategy of NORMA Group SE, the operational business development as well as the prospects of the company. For this reason, the management and the Investor Relations officers hold discussions with institutional investors, financial analysts and private shareholders over the course of the year. The company’s goal is to maintain constant, transparent and reliable communication with private and institutional investors as well as financial analysts.

The traditional communication formats include, on the one hand, legally required mandatory components such as Quarterly Statements, Half-year and Annual Reports, investor presentations and announcements. In this way, the company regularly informs its shareholders about the strategic and business development of the Group. On the other hand, NORMA Group’s Investor Relations team also focuses on continuously developing the digital communication formats and voluntary components of communication, such as the Online Annual Report, in line with the needs of the target audience.

The Management Board and the Investor Relations team conducted eleven mostly virtual roadshows with current and potential new investors in fiscal year 2022. NORMA Group was also represented at the following conferences:

Baader Investment Conference, Munich

Baader Investor Day, Munich

Berenberg European Conference 2022, Pennyhill, Great-Britain

Berenberg Madrid Seminar 2022, Madrid, Spain

Commerzbank & ODDO BHF Corporate Conference, Frankfurt/Main

Commerzbank German Investment Seminar, virtual

DZ Bank Equity Conference, Frankfurt/Main

Kepler Cheuvreux German Corporate Conference, virtual

Quirin Champions Conference, virtual

Quirin 14th MidCap Event, Geneva, Switzerland

Legend

These contents are part of the Non-financial Group Report and were subject to a separate limited assurance examination.